Literature DB >> 25138337

Seroprevalence of herpes simplex virus type 1 and 2 among pregnant women, 1989-2010.

Shani Delaney1, Carolyn Gardella1, Misty Saracino2, Amalia Magaret2, Anna Wald3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25138337      PMCID： PMC4414330          DOI： 10.1001/jama.2014.4359

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Neonatal herpes morbidity and mortality in California, 1995-2003.

Authors:  Sheldon R Morris; Heidi M Bauer; Michael C Samuel; Deborah Gallagher; Gail Bolan
Journal:  Sex Transm Dis       Date:  2008-01       Impact factor: 2.830

2.  Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.

Authors:  Heather Bradley; Lauri E Markowitz; Theda Gibson; Geraldine M McQuillan
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

3.  Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years--United States, 1988 to 2010.

Authors:  Robyn Neblett Fanfair; Akbar Zaidi; Lashan D Taylor; Fujie Xu; Sami Gottlieb; Lauri Markowitz
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

4.  Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.

Authors:  Rhonda Y Kropp; Thomas Wong; Louise Cormier; Allison Ringrose; Sandra Burton; Joanne E Embree; Marc Steben
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

5.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Authors:  Zane A Brown; Anna Wald; R Ashley Morrow; Stacy Selke; Judith Zeh; Lawrence Corey
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

6.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948
  6 in total
  7 in total

1.  Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains.

Authors:  Aaron W Kolb; Inna V Larsen; Jacqueline A Cuellar; Curtis R Brandt
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States.

Authors:  Monica E Patton; Kyle Bernstein; Gui Liu; Akbar Zaidi; Lauri E Markowitz
Journal:  Clin Infect Dis       Date:  2018-10-30       Impact factor: 9.079

3.  Long-term time trends in reactivated herpes simplex infections and treatment in Sweden.

Authors:  Karin Lopatko Lindman; Judith Lockman-Lundgren; Bodil Weidung; Jan Olsson; Fredrik Elgh; Hugo Lövheim
Journal:  BMC Infect Dis       Date:  2022-06-15       Impact factor: 3.667

Review 4.  Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.

Authors:  Christine Johnston; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

5.  Herpes virus seroepidemiology in the adult Swedish population.

Authors:  Jan Olsson; Eloise Kok; Rolf Adolfsson; Hugo Lövheim; Fredrik Elgh
Journal:  Immun Ageing       Date:  2017-05-10       Impact factor: 6.400

6.  First estimates of the global and regional incidence of neonatal herpes infection.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Lori M Newman; Sami L Gottlieb
Journal:  Lancet Glob Health       Date:  2017-01-31       Impact factor: 26.763

7.  Herpes simplex virus: global infection prevalence and incidence estimates, 2016.

Authors:  Charlotte James; Manale Harfouche; Nicky J Welton; Katherine Me Turner; Laith J Abu-Raddad; Sami L Gottlieb; Katharine J Looker
Journal:  Bull World Health Organ       Date:  2020-03-25       Impact factor: 9.408
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.